125 related articles for article (PubMed ID: 2837353)
1. Enzyme replacement in Fabry endothelial cells and fibroblasts: uptake experiments and electron microscopical studies.
Hasholt L; Wandall A; Sørensen SA
Clin Genet; 1988 May; 33(5):360-71. PubMed ID: 2837353
[TBL] [Abstract][Full Text] [Related]
2. ConA-mediated binding and uptake of purified alpha-galactosidase A in Fabry fibroblasts.
Hasholt L; Sørensen SA
Exp Cell Res; 1983 Oct; 148(2):405-11. PubMed ID: 6313412
[TBL] [Abstract][Full Text] [Related]
3. Loss of electron-dense lamellar material from Fabry's disease fibroblasts after enzyme replacement.
Sifers RN; Mayes JS; Nordquist RE
Hum Genet; 1983; 65(1):85-7. PubMed ID: 6315565
[TBL] [Abstract][Full Text] [Related]
4. Endocytosis of lysosomal alpha-galactosidase A by cultured fibroblasts from patients with Fabry disease.
Mayes JS; Cray EL; Dell VA; Scheerer JB; Sifers RN
Am J Hum Genet; 1982 Jul; 34(4):602-10. PubMed ID: 6285697
[TBL] [Abstract][Full Text] [Related]
5. Electron microscopic observations on cultured fibroblasts from Fabry heterozygotes and hemizygotes.
Wandall A; Hasholt L; Sørensen SA
Ultrastruct Pathol; 1982; 3(1):51-8. PubMed ID: 6280349
[TBL] [Abstract][Full Text] [Related]
6. Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease.
Mayes JS; Scheerer JB; Sifers RN; Donaldson ML
Clin Chim Acta; 1981 May; 112(2):247-51. PubMed ID: 6263521
[TBL] [Abstract][Full Text] [Related]
7. Lysosomal delivery of therapeutic enzymes in cell models of Fabry disease.
Marchesan D; Cox TM; Deegan PB
J Inherit Metab Dis; 2012 Nov; 35(6):1107-17. PubMed ID: 22450713
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Human Dermal Fibroblasts in Fabry Disease.
Lakomá J; Donadio V; Liguori R; Caprini M
J Cell Physiol; 2016 Jan; 231(1):192-203. PubMed ID: 26058984
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal alpha-galactosidase in endothelial cell cultures established from a Fabry hemizygous and normal umbilical veins.
Hasholt L; Sørensen SA
Hum Genet; 1986 Jan; 72(1):72-6. PubMed ID: 3002954
[TBL] [Abstract][Full Text] [Related]
10. Production in yeast of alpha-galactosidase A, a lysosomal enzyme applicable to enzyme replacement therapy for Fabry disease.
Chiba Y; Sakuraba H; Kotani M; Kase R; Kobayashi K; Takeuchi M; Ogasawara S; Maruyama Y; Nakajima T; Takaoka Y; Jigami Y
Glycobiology; 2002 Dec; 12(12):821-8. PubMed ID: 12499404
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast alpha-galactosidase A activity for identification of Fabry's disease heterozygotes.
Fensom AH; Benson PF; Grant AR; Jacobs L
J Inherit Metab Dis; 1980; 2(1):9-12. PubMed ID: 6273649
[TBL] [Abstract][Full Text] [Related]
12.
Kytidou K; Beekwilder J; Artola M; van Meel E; Wilbers RHP; Moolenaar GF; Goosen N; Ferraz MJ; Katzy R; Voskamp P; Florea BI; Hokke CH; Overkleeft HS; Schots A; Bosch D; Pannu N; Aerts JMFG
J Biol Chem; 2018 Jun; 293(26):10042-10058. PubMed ID: 29674318
[TBL] [Abstract][Full Text] [Related]
13. The fate of internalized alpha-2-macroglobulin: alpha-galactosidase conjugate in fibroblasts from Fabry's hemizygote.
Osada T; Kuroda Y; Ikai A
Biochem Biophys Res Commun; 1987 Mar; 143(3):954-8. PubMed ID: 2436620
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathology of Fabry's disease. Physical and kinetic properties of alpha-galactosidase A in cultured human endothelial cells.
Johnson DL; Desnick RJ
Biochim Biophys Acta; 1978 Jan; 538(2):195-204. PubMed ID: 23178
[No Abstract] [Full Text] [Related]
15. Molecular basis for globotriaosylceramide regulation and enzyme uptake in immortalized aortic endothelial cells from Fabry mice.
Meng XL; Day TS; McNeill N; Ashcraft P; Frischmuth T; Cheng SH; Liu ZP; Shen JS; Schiffmann R
J Inherit Metab Dis; 2016 May; 39(3):447-455. PubMed ID: 26960552
[TBL] [Abstract][Full Text] [Related]
16. A case of Fabry's disease in a patient with no alpha-galactosidase A activity caused by a single amino acid substitution of Pro-40 by Ser.
Koide T; Ishiura M; Iwai K; Inoue M; Kaneda Y; Okada Y; Uchida T
FEBS Lett; 1990 Jan; 259(2):353-6. PubMed ID: 2152885
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal glycosphingolipid storage in chloroquine-induced alpha-galactosidase-deficient human endothelial cells with transformation by simian virus 40: in vitro model of Fabry disease.
Inagaki M; Katsumoto T; Nanba E; Ohno K; Suehiro S; Takeshita K
Acta Neuropathol; 1993; 85(3):272-9. PubMed ID: 8384772
[TBL] [Abstract][Full Text] [Related]
18. Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients.
Navarro C; Teijeira S; Dominguez C; Fernandez JM; Rivas E; Fachal C; Barrera S; Rodriguez C; Iranzo P
Acta Neuropathol; 2006 Feb; 111(2):178-85. PubMed ID: 16463201
[TBL] [Abstract][Full Text] [Related]
19. A Fabry's disease heterozygote with a new mutation: biochemical, ultrastructural, and clinical investigations.
Hasholt L; Sørensen SA; Wandall A; Andersen EB; Arlien-Søborg P
J Med Genet; 1990 May; 27(5):303-6. PubMed ID: 2161929
[TBL] [Abstract][Full Text] [Related]
20. Endocytotic internalization of alpha-2-macroglobulin: alpha-galactosidase conjugate by cultured fibroblasts derived from Fabry hemizygote.
Osada T; Kuroda Y; Ikai A
Biochem Biophys Res Commun; 1987 Jan; 142(1):100-6. PubMed ID: 2434088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
